BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 2, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Pharmaceutical manufacturing

Tired of waiting for vaccines, PAHO proposes making its own

Aug. 26, 2021
By Mari Serebrov
With the Americas having the dubious distinction of the most COVID-19 cases in the world, the Pan American Health Organization (PAHO) is answering that “wake-up call” with plans to develop a collaborative platform to develop mRNA vaccine production in Latin America and the Caribbean.
Read More

Regulatory actions for Aug. 26, 2021

Aug. 26, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerami, Argenx, Blade, CTI, Moderna, RDIF, Taysha.
Read More

Other news to note for Aug. 26, 2021

Aug. 26, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Afimmune, Anixa, Aria, Avalo, Biontech, Betterlife, Beyondspring, Cassava, Cerecor, Chime, Cleveland Clinic, Combioxin, Context, CTI, DRI, Eagle, Eclipse, Effector, EOC, Eurofarma, Excision, Flame, FSD, Jiangsu Hengrui, Heat, Ibio, ICER, Kintor, Landos, Locust Walk, Lucid, Mindset, Molgenie, Novartis, Novarock, Noxopharm, Ocumension, Pfizer, PT Etana, Redhill, Rubryc, Seqens, Tyligand.
Read More

In the clinic for Aug. 26, 2021

Aug. 26, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affibody, Arcutis, Ascletis, Bluewillow, Bridgebio, Brii, Clarity, Cortexyme, Cytodyn, Emergent, Fibrogen, Flexion, FSD, IBT, Inmagene, Janssen, Lianbio, Lipocine, Merck, Novavax, Noxopharm, Rafael, Senhwa, Xrad.
Read More
RNA and SARS-CoV-2 virus cell

NIH announces novel COVID sample prep approach for testing for COVID-19

Aug. 25, 2021
By Mark McCarty
The U.S. National Institutes of Health (NIH) said it has developed a novel method of sample preparation for tests for the SARS-CoV-2 virus, which could trim time and costs for diagnostic testing for COVID-19. This approach bypasses the RNA extraction step, thus eliminating the need for some supplies, and NIH said this technique is available for co-development or licensing with the private sector, giving the smart testing company access to a patent-protected technology with an existing demand already built in.
Read More
Health care worker in PPE administers nasal swab test

Diagnostic may better identify contagious COVID-19 subjects, those at risk of developing more severe symptoms

Aug. 25, 2021
By Bernard Banga
PARIS – A consortium led by French clinical and scientific experts has just published results in the Journal of Experimental Medicine of a study showing the contribution of a new simplified diagnostic test in better identifying the level of contagiousness of subjects infected with SARS-CoV-2.
Read More

Other news to note for Aug. 25, 2021

Aug. 25, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott Laboratories, Alpha Healthcare, Anatomage, Baylis, Bioaesthetics, Biosyent, Boston Scientific, Elekta, Healthcare Services Group, Helius Medical Technologies, Humacyte, ID Genomics, Iotron Medical Meadowlands Diagnostics, Osteoid, Photocure, Provista Diagnostics.
Read More

Brii’s SARS-CoV-2 monoclonal antibody cocktail therapy positive in phase III trial

Aug. 25, 2021
By Doris Yu
Brii Biosciences Ltd. made strides toward getting its SARS-CoV-2 neutralizing monoclonal antibody combination therapy, BRII-196/BRII-198, to market with positive interim phase III data that show high-risk outpatients may benefit from the combination therapy up to 10 days following symptom onset.
Read More
Drug vials and syringe

Case for COVID-19 booster shots strengthens with data from J&J and UK

Aug. 25, 2021
By Richard Staines
Johnson & Johnson has announced new data supporting use of its COVID-19 vaccine as a booster shot, after separate trial data from the U.K. showed effects of several vaccines waned after six months.
Read More

Regulatory actions for Aug. 25, 2021

Aug. 25, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB, Abbvie, Alimera, Antengene, Avidity, Bio-Path, Cara, Cardiol, Cassava, Celltrion, Humanetics, Immunocore, Index, Janssen, Polarityte, PTC, Roche, Stealth, Tonix, Vifor.
Read More
Previous 1 2 … 193 194 195 196 197 198 199 200 201 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 31, 2025.
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • IMV-101 shows promise for B-cell malignancies

    BioWorld Science
    IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing